Citations 1
Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S
Kozloff, M., Cohn, Allen Lee, Christiansen, N., Flynn, Patrick J. , Kabbinavar, Fairooz F. , Robles, Robert, Sarkar, Somnath , Hambleton, J., Yood, Marianne Ulcickas , Grothey, Axel
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3566-3566
